MD (Hons), BA, BSc, MSc, DPhil (Oxford), FFPH
Visiting Professor of Cognitive Health Economics
- Visiting Professor at the Department of Psychiatry, University of Oxford
- Professor of Health Economics, Head of Department, Deputy Head of Center at the Department of Health Economics, Centre for Public Health, Medical University of Vienna
- Research Associate at the Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford
- Honorary Professor, Corvinus University Budapest
Oxford Mental Health Economics and Policy
I am currently Visiting Professor of Cognitive Health Economics at the Department of Psychiatry, University of Oxford and Professor of Health Economics and Chair of the Department of Health Economics, Centre for Public Health at the Medical University of Vienna. I have over 20 years research collaboration with the Department in the area of mental health economics including the CEQUEL, OXTEXT, OCTET, PreDicT, PAX-D and PETRUSHKA trials and the development of the OxCAP-MH instrument through the operationalisation of the capabilities approach for outcome measurement in mental health research.
I hold a DPhil in Public Health from the University of Oxford; an MSc in Health Economics from the University of York; and a Doctor of Medicine (MD), a BSc in Economics and a BA in Medical Translation from the University of Szeged. I was elected for Fellow of the UK Faculty of Public Health through Distinction in 2014.
My main expertise is applied and methodological economic evaluation and outcomes research linked to clinical trials and through modelling primarily in the fields of mental health, public health, perinatal and palliative care, and various chronic diseases. Other long ongoing research interests include cost-effective clinical guideline/HTA development; broader system-level evaluation and international comparison of health services; and comparative health systems and health care rationing research including personalized care.
Operationalising the capability approach for outcome measurement in mental health research.
Simon J. et al, (2013), Soc Sci Med, 98, 187 - 196
Economic evaluations in bipolar disorder: a systematic review and critical appraisal
Abdul Pari AAH. et al, (2014), Bipolar disorders, 16, 557 - 582
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
Barnes TRE. et al, (2016), Health Technol Assess, 20, 1 - 46
Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial.
Geddes JR. et al, (2016), Lancet Psychiatry, 3, 31 - 39